Danaher (DHR) -14% at Monday July 21 open despite Q2 beat — adj EPS <meta name="viewport" content="width=device-width, initial-scale=1.0" />.94 vs <meta name="viewport" content="width=device-width, initial-scale=1.0" />.83 est and revenue $6.27B vs $6.10B est top the Street, but FY26 core revenue guide cut to 3–4% (from 3–6%) and bioprocessing outlook trimmed to mid-single-digit growth (from high-single-digit) after CEO Rainer Blair cites 'customer project timing'

.94 vs .83 est and revenue $6.27B vs $6.10B est top the Street, but FY26 core revenue guide cut to 3–4% (from 3–6%) and bioprocessing outlook trimmed to mid-single-digit growth (from high-single-digit) after CEO Rainer Blair cites 'customer project timing'" /> .94 vs .83 est and revenue $6.27B vs $6.10B est top the Street, but FY26 core revenue guide cut to 3–4% (from 3–6%) and bioprocessing outlook trimmed to mid-single-digit growth (from high-single-digit) after CEO Rainer Blair cites 'customer project timing'" />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.